Item 1.01 Entry Into a Material Definitive Agreement.

On April 28, 2023, the Drug Enforcement Administration ("DEA") notified the Bright Green Corporation (the "Company") that it had received a Schedule I controlled substance bulk manufacturer registration ("DEA Registration"). The Company's Registration Number is RB0649383, and the DEA Registration expires on July 31, 2024. The DEA Registration permits the company to cultivate and manufacture cannabis, cannabis extract, and tetrahydrocannabinol to supply DEA registered researchers in the U.S. and globally, and to produce these substances for use in pharmaceutical production of prescription medicines within the U.S. The Company must comply with the terms of the Memorandum of Agreement ("MOA"), which was executed with the DEA on April 27, 2023, and include:





  ? submitting an Individual Procurement Quota on or before April 1 of each year
    utilizing DEA Form 250;
  ? submitting an Individual Manufacturing Quota on or before May 1 of each year
    utilizing DEA Form 189;
  ? collecting samples of cannabis and distributing them to DEA-registered
    analytical laboratories for chemical analysis during the pendency of
    cultivation and prior to the DEA's taking possession of the cannabis grown;
  ? providing the DEA with 15-day advance written notification, via email, of its
    intent to harvest cannabis;
  ? following the DEA's packaging, labeling, storage and transportation
    requirements;
  ? distributing DEA's stocks of cannabis to buyers who entered into bona fide
    supply agreements with the Company;
  ? providing the DEA with 15-day advance written notification of its intent to
    distribute cannabis; and
  ? invoicing the DEA for harvested cannabis that it intends to sell to the DEA.

Finally, the Company's MOA with the DEA contains an Addendum ("MOA Addendum") stating certain conditions for the Company's hemp activities, and specifying that the Company's hemp activities are not subject to the terms or requirements of the MOA since hemp is not a controlled substance and was made legal by the Agriculture Improvement Act of 2018 (the "2018 Farm Bill"), which has been codified in 21 C.F.R. § 1308.11(d)(31)(ii)), 21 U.S.C. § 802(16)(B)(i), and 7 U.S.C. § 1639o.

Copies of the MOA and the MOA Addendum are filed as Exhibit 10.1 and Exhibit 10.2 to this Current Report on Form 8-K, respectively, and are incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits





(d) Exhibits

Exhibits.

Exhibit Number   Description
10.1               Memorandum of Agreement, dated April 27, 2023
10.2               Addendum to Memorandum of Agreement, dated April 27, 2023
104              Cover Page Interactive Data File (embedded within the Inline XBRL
                 document)

© Edgar Online, source Glimpses